ClinicalTrials.Veeva

Menu

Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal Cancer

Samsung Medical Center logo

Samsung Medical Center

Status

Unknown

Conditions

Colonic Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT00516230
SMC-2007-04-080

Details and patient eligibility

About

Correct identification of Lynch syndrome at the time of colorectal cancer presentation is important. We aim to find best ways to screen patients with colorectal cancer in Korea.

Full description

Patients with newly diagnoised colorectal cancer will be eligible. They will undergo detailed history taking including family history, and molecular stuidies including microsatellite instability test and immunohistochemistry for DNA mismatch repair protein with pre-selection. Any abnormal finding in molecular stuides will be offered genetic testing (after testing methylation status for patients with abnormalities in MLH1).

Enrollment

200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Colorectal cancer

Exclusion criteria

  • Histology showing other than adenocarcinoma

Trial contacts and locations

1

Loading...

Central trial contact

Tae Kuen Kim; Dong Kyung Chang, M.D. Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems